CD4 and inflammatory bowel disease: From 1988 to 2018, studies have gradually reported that ERCs derived from menstrual blood were able to regulate series of immunological responses between CD3+CD25+ T lymphocytes and CD4+CD25+Foxp3+ Treg cells in IBD [34].